APTO Aptose Biosciences Inc

USD 1.27 0.01 0.793651
Icon

Aptose Biosciences Inc (APTO) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.27

+0.01 (+0.79)%

USD 0.02B

0.03M

USD 9.33(+634.91%)

N/A

Icon

APTO

Aptose Biosciences Inc (USD)
COMMON STOCK | NSD
USD 1.27
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 1.27

Aptose Biosciences Inc (APTO) Stock Forecast

Show ratings and price targets of :
USD 9.33
(+634.91%)

Based on the Aptose Biosciences Inc stock forecast from 2 analysts, the average analyst target price for Aptose Biosciences Inc is USD 9.33 over the next 12 months. Aptose Biosciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Aptose Biosciences Inc is Very Bearish, which is based on 0 positive signals and 7 negative signals. At the last closing, Aptose Biosciences Inc’s stock price was USD 1.27. Aptose Biosciences Inc’s stock price has changed by -7.97% over the past week, -15.33% over the past month and -83.25% over the last year.

No recent analyst target price found for Aptose Biosciences Inc
No recent average analyst rating found for Aptose Biosciences Inc

Company Overview Aptose Biosciences Inc

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatmen...Read More

https://www.aptose.com

251 Consumers Road, Toronto, ON, Canada, M2J 4R3

35

December

USD

USA

Adjusted Closing Price for Aptose Biosciences Inc (APTO)

Loading...

Unadjusted Closing Price for Aptose Biosciences Inc (APTO)

Loading...

Share Trading Volume for Aptose Biosciences Inc Shares

Loading...

Compare Performance of Aptose Biosciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for APTO

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aptose Biosciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +0.38 (+0.10%) USD107.38B 29.93 21.06

ETFs Containing APTO

Symbol Name APTO's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aptose Biosciences Inc (APTO) Stock

Based on ratings from 2 analysts Aptose Biosciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 3 buy, sell and hold ratings.

Unfortunately we do not have enough data on APTO's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for APTO is USD 9.33 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 5.

Unfortunately we do not have enough data on APTO's stock to indicate if its overvalued.

The last closing price of APTO's stock was USD 1.27.

The most recent market capitalization for APTO is USD 0.02B.

Based on targets from 2 analysts, the average taret price for APTO is projected at USD 9.33 over the next 12 months. This means that APTO's stock price may go up by +634.91% over the next 12 months.

We can't find any ETFs which contains Aptose Biosciences Inc's stock.

As per our most recent records Aptose Biosciences Inc has 35 Employees.

Aptose Biosciences Inc's registered address is 251 Consumers Road, Toronto, ON, Canada, M2J 4R3. You can get more information about it from Aptose Biosciences Inc's website at https://www.aptose.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...